Lipospheres for Simultaneous Controlled Release and Improved Pharmacokinetic Profiles of Saxagliptin-Enalapril: Formulation, Optimization, and Comparative In Vitro-In Vivo Evaluation.
作者:
主题词
金刚烷(Adamantane);投药, 口服(Administration, Oral);动物(Animals);抗高血压药(Antihypertensive Agents);生物利用度(Biological Availability);迟效制剂(Delayed-Action Preparations);二肽类(Dipeptides);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);依那普利(Enalapril);半衰期(Half-Life);人类(Humans);粒子大小(Particle Size);蜡类(Waxes)
DOI
10.1208/s12249-020-01733-w
PMID
32651896
发布时间
2020-10-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文